Edwards Lifesciences (XSWX:EW) Inventories, Finished Goods: CHF531 Mil (As of Mar. 2026)


XSWX:EW Edwards Lifesciences Corp XSWX:EW
97 GF Score
Price CHF72.91
GF Value CHF75.73
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Inventories, Finished Goods?

Edwards Lifesciences XSWX:EW +0.37% 97 Inventories, Finished Goods is CHF531 Mil as of Mar. 2026. GuruFocus rates XSWX:EW with a GF Score™ of 97/100 and a GF Value™ of CHF75.73. The stock has 5 warning signs investors should review.

Edwards Lifesciences's quarterly finished goods increased from Sep. 2025 (CHF511 Mil) to Dec. 2025 (CHF539 Mil) but then declined from Dec. 2025 (CHF539 Mil) to Mar. 2026 (CHF531 Mil).

Edwards Lifesciences's annual finished goods increased from Dec. 2023 (CHF442 Mil) to Dec. 2024 (CHF543 Mil) but then declined from Dec. 2024 (CHF543 Mil) to Dec. 2025 (CHF539 Mil).

Edwards Lifesciences Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Inventories, Finished Goods Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 395.66 504.65 442.26 543.34 539.26

Edwards Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 525.30 512.72 511.26 539.26 530.96
XSWX:EW
97GF Score
Edwards Lifesciences Corp XSWX:EW
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of CHF531 Mil mean?
Edwards Lifesciences (XSWX:EW) has a Inventories, Finished Goods of CHF531 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Inventories, Finished Goods too high?
Edwards Lifesciences' current Inventories, Finished Goods is CHF531 Mil. Overall, Edwards Lifesciences has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Inventories, Finished Goods compare to DXCM and GEHC?
Edwards Lifesciences' Inventories, Finished Goods of CHF531 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Inventories, Finished Goods is CHF531 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Edwards Lifesciences (XSWX:EW) has a current Inventories, Finished Goods of CHF531 Mil. The stock's GF Value™ is CHF75.73, compared to a current price of CHF72.91 — trading 3.7% below its estimated fair value. The current Inventories, Finished Goods is CHF531 Mil. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Edwards Lifesciences (XSWX:EW), the current Inventories, Finished Goods is CHF531 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of CHF72.91 is trading 3.7% below its estimated GF Value™ of CHF75.73.

Key valuation signals for XSWX:EW:

  • Inventories, Finished Goods: CHF531 Mil
  • GF Value™: CHF75.73 vs. price of CHF72.91 (3.7% below fair value)
  • GF Score™: 97/100 with 5 warning signs

No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score

Get the complete analysis for XSWX:EW

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF72.91
Price
CHF75.73
GF Value